Track papers across labs, topics, and trends.
Search papers, labs, and topics across Lattice.
1
0
0
3
Cadonilimab‐containing regimen achieved promising efficacy and an acceptable safety profile as first‐line therapy for R/M CC, and biomarker findings are exploratory and provide preliminary evidence for future research on bispecific‐antibody resistance.